Author: He, Jiayang; Li, Zhengtu; Huang, Wanyi; Guan, Wenda; Ma, Hongxia; Yang, Zi feng; Wang, Xinhua
Title: Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial Document date: 2019_4_2
ID: vn9e5nm3_129
Snippet: Adverse events leading to discontinuation of treatment or serious adverse events will be 489 summarised. In addition, the 95% confidence interval of adverse events using the Fisher's exact test 490 will be calculated and the Fisher's exact test will be used to compare the prevalence of adverse 491 events between the CLD granules, oseltamivir and placebo 28 . informed consents will be obtained from all participants before entry into the study; vol.....
Document: Adverse events leading to discontinuation of treatment or serious adverse events will be 489 summarised. In addition, the 95% confidence interval of adverse events using the Fisher's exact test 490 will be calculated and the Fisher's exact test will be used to compare the prevalence of adverse 491 events between the CLD granules, oseltamivir and placebo 28 . informed consents will be obtained from all participants before entry into the study; voluntary 502 participation will be ensured and utmost confidentiality of the information tendered during the 503 interview will be required. The trial will be monitored by the Ethics Committee. treatment during rehabilitation, the placebo control group will be provided with basic drugs.
Search related documents:
Co phrase search for related documents- adverse event and exact test: 1, 2, 3
- adverse event and Fisher exact test: 1
- adverse event and informed consent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- adverse event and placebo control group: 1, 2, 3
- adverse event and treatment discontinuation: 1, 2, 3, 4, 5, 6
- adverse event confidence interval and confidence interval: 1, 2, 3, 4, 5
- adverse event treatment discontinuation and confidence interval: 1
- adverse event treatment discontinuation and treatment discontinuation: 1
- basic drug and exact test: 1
- confidence interval and exact test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- confidence interval and Fisher exact test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- confidence interval and informed consent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- confidence interval and placebo control group: 1, 2, 3, 4, 5, 6, 7, 8
- confidence interval and rehabilitation treatment: 1, 2
- confidence interval and study entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- confidence interval and treatment discontinuation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- exact test and Fisher exact test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- exact test and informed consent: 1, 2, 3, 4, 5, 6, 7, 8, 9
- exact test and placebo control group: 1, 2
Co phrase search for related documents, hyperlinks ordered by date